Trending News
News
News
Optibrium and Certara Collaborate
Collaboration will see integration of Optibrium’s StarDrop and Certera’s D360 platform.
News
Flagship Biosciences Customizes Assay Development and Tissue Image Analysis
Flagship Biosciences and ACD collaborate to develop quantitative RNAscope® assays for pharmaceutical clinical trials in the CLIA environment.
News
Aprea Presents Preliminary Clinical Phase Ib/II Results in Ovarian Cancer at AACR
Company presents results with APR-246 - a novel candidate drug that restores mutant p53 protein into its wild-type function.
News
Drugs that Activate Brain Stem Cells May Reverse Multiple Sclerosis
NIH-funded study identifies over-the-counter compounds that may replace damaged cells.
News
Horizon Discovery & Thermo Agreement
Horizon Discovery Group plc and Thermo Fisher Scientific sign supply and commercialization agreement, which will see Thermo market and distribute Horizon’s X-MAN cell line collection.
News
Long Term Clinical Data from PISCES Stroke Trial
Long term data continue to show good safety profile and evidence of sustained improvements in neurological status and limb function.
News
Sartorius Stedim Biotech Acquires BioOutsource
Aquisition will enable Sartorius to offer increased support to their biopharma clients.
News
Could Maple Syrup Help Cut Use Of Antibiotics?
Syrup extract found to make antibiotics more effective against bacteria.
News
MRC Technology Appoints Finance Director
MRC Technology, an independent life science medical research charity, has appointed Andrew Mercieca as its Finance Director from 1 April 2015. Andrew joined the company as Interim Finance Director in August 2014.
News
Isarna Initiates First-in-Human Phase I Trial for ISTH0036
Phase I trial designed to evaluate the safety and long-term tolerability of ISTH0036 in patients with advanced glaucoma.
Advertisement